Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endocyte Inc (NASDAQ:ECYT)

3.77
Delayed Data
As of May 26
 -0.10 / -2.58%
Today’s Change
2.65
Today|||52-Week Range
6.34
-5.99%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues34.7M64.9M70.4M70.0K
 
 
 
 
 
Depreciation And Amortization358.4K674.7K857.1K886.7K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses50.4M82.5M59.1M41.0M
 
 
 
 
 
Research And Development35.7M57.9M37.5M26.2M
 
 
 
 
 
Total Operating Expenses50.7M83.2M59.9M41.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-16.0M-18.3M10.4M-41.8M
 
 
 
 
 
Extraordinary Charge0.000.00-5.4M-134.0K
 
 
 
Interest Expense On Debt629.0K2.5K1.2K0.00
 
 
 
 
Other Expenses-947.8K-153.7K-144.7K51.6K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-17.3M-18.0M5.5M-41.3M
 
 
 
 
 
Net Income-17.3M-18.0M5.5M-41.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS35.9M36.0M40.2M41.9M
 
 
 
 
 
Shares To Calculate EPS Diluted35.9M36.0M41.8M41.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.48-$0.50$0.13-$0.98
 
 
 
 
 
EPS Diluted-$0.48-$0.50$0.13-$0.98